June 2008. Volume 4. Number 2

La vacuna triple vírica administrada entre los 12-23 meses de edad se asocia con un mayor riesgo de púrpura trombocitopénica

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB et al. Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121:e687-92
Reviewers: García Vera C1, Aizpurua Galdeano P2.
1 Centro de Salud Sagasta-Ruiseñores. Zaragoza. España.
2ABS 7 La Salut Badalona. Badalona. España.
Correspondence: César García Vera. Email: cgarciav@wanadoo.es
Acceptance date: 13/05/2008
Publication date: 01/06/2008

Abstract

How to cite this article

García Vera C, Aizpurua Galdeano P. La vacuna triple vírica administrada entre los 12-23 meses de edad se asocia con un mayor riesgo de púrpura trombocitopénica. Evid Pediatr. 2008;4:37

AVC | Critically appraised articles

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB et al. Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121:e687-92
Reviewers: García Vera C1, Aizpurua Galdeano P2.
1 Centro de Salud Sagasta-Ruiseñores. Zaragoza. España.
2ABS 7 La Salut Badalona. Badalona. España.
Correspondence: César García Vera. Email: cgarciav@wanadoo.es
Acceptance date: 13/05/2008
Publication date: 01/06/2008

How to cite this article

García Vera C, Aizpurua Galdeano P. La vacuna triple vírica administrada entre los 12-23 meses de edad se asocia con un mayor riesgo de púrpura trombocitopénica. Evid Pediatr. 2008;4:37

References

  1. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99:765-73.
  2. Institute of Medicine. Measles and mumps vaccines. In: Stratton KR, Howe CJ, Johnston RB, eds. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press;1994.p.118–86.
  3. Miller E, Waight P, Farrington C, Andrews N, Stowe J, Taylor B Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84:227-9.
  4. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55:107-11.
  5. Rajantie J, Zeller B, Treutiger I, Rosthöj J . NOPHO working group and five national study groups. Vaccination associated thrombocytopenic purpura in children. Vaccine. 2007;25:1838-40.
  6. Miller E, Waight P, Farrington P, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84:227-9.
01/06/2008

Linked Comment